rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Exelon

Subscribe via RSS
Rediff.com  »  News  »   Exelon

  News for Exelon

  • News
  • Business

Nuclear energy, inevitable disaster: Worth it?

Gopal Krishna makes a case against the nuclear liability bill. Even as the Parliamentary Standing Committee was busy taking submission and testimonies from citizens and experts in India in the......

Dr Reddy's may launch three new drugs in US

 Pharma major Dr Reddy's Laboratories (DRL) may launch three new drugs, which have been successfully come out of legal tangle, in the next fiscal in the USA market.According to Dr Reddy's,......

Now, Pfizer, Novartis, GSK under USFDA scanner

 Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck......

Infosys 9th on 'The Wired 40' list

 Bangalore-based Infosys Technologies is the only Indian company to make it to the Wired magazine's 'The Wired 40' list.The Wired 401Apple Computer2Google3Samsung......

PFC Energy 50 - Fourth Quarter 2004

 Rank31/12/04CompanyMarket Value12/31/04($US Bill.)Share PriceChange(YoY)HQCountryPrimaryBusiness1EXXONMOBIL$330.725.0% USOil & Gas2BP$210.020.2% UKOil & Gas3RD/SHELL$201.911.1% UK/NethOil &......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2024 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances